๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to (1) evaluate the effect of caloric intake o...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-04
Trial ID
NCT01080612
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2010-01
Trial ID
NCT01065012
This trial is conducted in South Africa. The aim of this trial is to invest...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2002-03-20
Trial ID
NCT01486381
Treatments Being Tested
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-06-05
Trial ID
NCT05762419
Treatments Being Tested
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
Brief Summary The goal of this clinical trial is to learn which type of exe...
Status
Enrolling By Invitation
Location
Dow University of Health Sciences Ojha Campus
Start Date
2026-06-08
Trial ID
NCT07670728
Treatments Being Tested
To evaluate safety, tolerance and efficacy of TASO(TGF-ฮฒ2 targeting anti-se...
Status
Completed
Location
Seoul National University Hospital
Start Date
2021-03-09
Trial ID
NCT04862767
Treatments Being Tested
This study is a Phase I, single-center, randomized, double-blind, placebo-c...
Status
Completed
Location
SGS clinical pharmacology unit
Start Date
2016-10-18
Trial ID
NCT03102567
The primary objective of the study is to assess the relative bioavailabilit...
Status
Completed
Location
Teva Investigational Site 12141
Start Date
2025-03-10
Trial ID
NCT06911567
Treatments Being Tested